Global markets live: Microsoft, Micron, Nvidia, JPMorgan, Shell…
Every day, the MarketScreener team selects the most important news about listed companies worldwide. Here's a short summary for your convenience:

North America:
- Microsoft is experiencing disagreements with OpenAI over an AGI contract clause and faces a lawsuit from authors over AI model training.
- Micron Technology saw a surge in shares due to robust Q3 financial results driven by AI memory chip demand.
- Meta expanded its superintelligence team by hiring OpenAI researchers and won a copyright lawsuit related to AI training.
- Nvidia shares surged due to strong demand and optimistic predictions for AI-related chips.
- FedEx shares dropped 6% due to a lowered profit forecast influenced by volatile demand and U.S. tariffs.
- JPMorgan traders face challenges acquiring private credit loans due to a shortage of sellers.
- J.P. Morgan Asset Management launched its largest active ETF.
- Pfizer's experimental drug Hympavzi met primary objectives in a phase 3 study for hemophilia A or B.
- Tesla's robotaxi testing in Texas encountered driving errors and raised safety concerns.
- Brookfield Asset Management sold Aveo to The Living Company for $2.5 billion.
Europe:
- Shell denies considering a takeover of BP despite reports of potential acquisition talks.
-
H&M's Q2 earnings surpassed expectations, leading to a rise in share prices and plans to adjust its US strategy.
- Equinor and partners plan to invest approximately $2.1 billion in Norwegian oil and gas projects.
- EnBW plans a capital increase of up to 3.1 billion euros to fund investment initiatives.
- Mediobanca acquired EUR11 million of its own shares amidst Italian market activities.
- Moonpig's CEO is set to depart amid forecasts of slower earnings growth through 2026.
Rest of the world
- Biren Technology raised significant funding and plans for a Hong Kong IPO.
- Maersk resumed accepting import cargo at Haifa port and is suing over a $1 billion Brazil port auction.
- JSW Steel filed a review petition against the Supreme Court's decision on Bhushan Power.
- Eli Lilly's weight-loss drug Mounjaro has been approved in India to compete with Novo Nordisk's Wegovy.
- BHP is facing a UK contempt charge related to the Brazil dam collapse.
© MarketScreener.com -
2025